Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward Yu

Showing results (121-130 of 142) with videos related to

Pageof 15
Sort By:
Radiation Oncology (London, England)|January 29, 2017
Short report: interim safety results for a phase II trial measuring the integration of stereotactic ablative radiotherapy (SABR) plus surgery for early stage non-small cell lung cancer (MISSILE-NSCLC)David A Palma, Timothy K Nguyen, Keith Kwan, et al.
Breast Cancer Research and Treatment|July 8, 2020
Genetic and clinical predictors of arthralgia during letrozole or anastrozole therapy in breast cancer patientsAdrienne E Borrie, Finnley A Rose, Yun-Hee Choi, et al.
Practical Radiation Oncology|November 20, 2023
Real-World Utilization of Radiation Therapy in Multiple Myeloma: An Analysis of the Connect MM RegistryLeslie Ballas, Sikander Ailawadhi, Mohit Narang, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 27, 2024
Characteristics and Treatment Patterns of Long-surviving Patients With Multiple Myeloma: Over 13 Years of Follow-up in the Connect<sup>Ⓡ</sup> MM RegistryHoward R Terebelo, James Omel, Lynne I Wagner, et al.
BMC Cancer|July 8, 2022
Circulating tumor cells detected in follow-up predict survival outcomes in tri-modality management of advanced non-metastatic esophageal cancer: a secondary analysis of the QUINTETT randomized trialEdward Yu, Alison L Allan, Michael Sanatani, et al.
Cureus|January 17, 2020
A Phase II Multi-institutional Clinical Trial Assessing Fractionated Simultaneous In-Field Boost Radiotherapy for Brain OligometastasesGeorge Rodrigues, Slav Yartsev, David Roberge, et al.
Journal of Neuro-Oncology|April 17, 2016
Assessment of function and quality of life in a phase II multi-institutional clinical trial of fractionated simultaneous in-field boost radiotherapy for patients with 1-3 metastasesGlenn Bauman, Slav Yartsev, David Roberge, et al.
Scientific Reports|March 1, 2019
Metabolites related to purine catabolism and risk of type 2 diabetes incidence; modifying effects of the TCF7L2-rs7903146 polymorphismChristopher Papandreou, Jun Li, Liming Liang, et al.
The American Journal of Clinical Nutrition|February 24, 2019
Plasma metabolites predict both insulin resistance and incident type 2 diabetes: a metabolomics approach within the Prevención con Dieta Mediterránea (PREDIMED) studyChristopher Papandreou, Mònica Bulló, Miguel Ruiz-Canela, et al.
Breast Cancer Research and Treatment|August 11, 2018
Letrozole concentration is associated with CYP2A6 variation but not with arthralgia in patients with breast cancerAdrienne E Borrie, Rhiannon V Rose, Yun-Hee Choi, et al.
Pageof 15

Showing results (121-130 of 142) with videos related to

Sort By:
Pageof 15
Radiation Oncology (London, England)|January 29, 2017
Short report: interim safety results for a phase II trial measuring the integration of stereotactic ablative radiotherapy (SABR) plus surgery for early stage non-small cell lung cancer (MISSILE-NSCLC)David A Palma, Timothy K Nguyen, Keith Kwan, et al.
Breast Cancer Research and Treatment|July 8, 2020
Genetic and clinical predictors of arthralgia during letrozole or anastrozole therapy in breast cancer patientsAdrienne E Borrie, Finnley A Rose, Yun-Hee Choi, et al.
Practical Radiation Oncology|November 20, 2023
Real-World Utilization of Radiation Therapy in Multiple Myeloma: An Analysis of the Connect MM RegistryLeslie Ballas, Sikander Ailawadhi, Mohit Narang, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 27, 2024
Characteristics and Treatment Patterns of Long-surviving Patients With Multiple Myeloma: Over 13 Years of Follow-up in the Connect<sup>Ⓡ</sup> MM RegistryHoward R Terebelo, James Omel, Lynne I Wagner, et al.
BMC Cancer|July 8, 2022
Circulating tumor cells detected in follow-up predict survival outcomes in tri-modality management of advanced non-metastatic esophageal cancer: a secondary analysis of the QUINTETT randomized trialEdward Yu, Alison L Allan, Michael Sanatani, et al.
Cureus|January 17, 2020
A Phase II Multi-institutional Clinical Trial Assessing Fractionated Simultaneous In-Field Boost Radiotherapy for Brain OligometastasesGeorge Rodrigues, Slav Yartsev, David Roberge, et al.
Journal of Neuro-Oncology|April 17, 2016
Assessment of function and quality of life in a phase II multi-institutional clinical trial of fractionated simultaneous in-field boost radiotherapy for patients with 1-3 metastasesGlenn Bauman, Slav Yartsev, David Roberge, et al.
Scientific Reports|March 1, 2019
Metabolites related to purine catabolism and risk of type 2 diabetes incidence; modifying effects of the TCF7L2-rs7903146 polymorphismChristopher Papandreou, Jun Li, Liming Liang, et al.
The American Journal of Clinical Nutrition|February 24, 2019
Plasma metabolites predict both insulin resistance and incident type 2 diabetes: a metabolomics approach within the Prevención con Dieta Mediterránea (PREDIMED) studyChristopher Papandreou, Mònica Bulló, Miguel Ruiz-Canela, et al.
Breast Cancer Research and Treatment|August 11, 2018
Letrozole concentration is associated with CYP2A6 variation but not with arthralgia in patients with breast cancerAdrienne E Borrie, Rhiannon V Rose, Yun-Hee Choi, et al.
Pageof 15